about
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trialAlpha interferon and ribavirin combination therapy of chronic hepatitis D.Sexual transmission of HCV between spouses.2-Year GLOBE trial results: telbivudine Is superior to lamivudine in patients with chronic hepatitis B.Pegylated interferon Alfa-2b monotherapy and pegylated interferon Alfa-2b plus lamivudine combination therapy for patients with hepatitis B virus E antigen-negative chronic hepatitis B.Intrahepatic and peripheral T-cell responses in genotype 1b hepatitis C virus-infected patients with persistently normal and elevated aminotransferase levels.Durability of sustained virologic response in chronic hepatitis C.Lessons Learned From Review of a Single Center Experience With 500 Consecutive Liver Transplants in a Region With Insufficient Deceased-Donor Support.A randomized trial of peginterferon alpha-2a with or without ribavirin for HBeAg-negative chronic hepatitis B.Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels.Occult HBV infection and YMDD variants in hemodialysis patients with chronic HCV infection.Quantitative HBsAg and HDV-RNA levels in chronic delta hepatitis.Terlipressin and albumin combination treatment in hepatorenal syndrome.Intestinal metaplasia of the gastric cardia: a study from Turkey.Are acquired hepatocerebral degeneration and hepatic myelopathy reversible?Ulcerative colitis: analyses of 116 cases (do extraintestinal manifestations effect the time to catch remission?).Cyclosporin for severe ulcerative colitis attacks.Prevalence and virological features of occult hepatitis B virus infection in female sex workers who work uncontrolled in Turkey.Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon alpha-2b.Relationships between hemodynamic alterations and Child-Pugh Score in patients with cirrhosis.
P50
Q28301659-081ED57D-FBF7-464E-996F-88E96A50FA50Q33856581-025803AF-E95B-4CE8-AB1C-57D68AC10064Q34556147-B9629195-5386-45CE-B090-DC5229A14DAFQ34600796-F0769A2F-59E4-4075-B4A7-AC99DC41F595Q35912766-06922494-945D-4B87-A844-116033CB5BD0Q36491605-7A4B1DE0-5576-47B8-B175-D17796F0E42EQ37046571-5FD533D7-F63C-4B82-B864-F9DF987EE78FQ38510761-089D097E-9F11-4D78-AC44-E186396D9DDCQ42165788-80E1E39C-1CF9-4B12-9901-9CDD740A8795Q42947260-654AD758-973F-4D91-92FF-71931636E748Q43049089-04AA3F02-6629-4CB0-8792-C1CA910A1AE7Q43493773-4DAE880C-BEA3-4310-A4D4-E5C0F34A0EB7Q43666089-E3E0755B-91C0-4156-B082-0E7AFAD45594Q44080130-DE8C2DF5-ED97-4822-AC1B-BA3FA612095FQ44285148-8D80FC77-13CD-4831-8F68-131E5816753AQ44896381-CB1B916D-7E91-44DB-B49F-B01B730D0DACQ44971083-BA313359-D72F-4DEB-A0EA-0CB290085323Q45239553-AAD6C333-9665-41D4-AADB-5E32B6A8588CQ46514441-E0F17A56-CCE2-4C71-9A40-9648462ABC0DQ46732709-04397924-D47C-433F-9241-7A53FA39F56F
P50
name
Yilmaz Cakaloglu
@ast
Yilmaz Cakaloglu
@en
Yilmaz Cakaloglu
@es
Yilmaz Cakaloglu
@nl
type
label
Yilmaz Cakaloglu
@ast
Yilmaz Cakaloglu
@en
Yilmaz Cakaloglu
@es
Yilmaz Cakaloglu
@nl
prefLabel
Yilmaz Cakaloglu
@ast
Yilmaz Cakaloglu
@en
Yilmaz Cakaloglu
@es
Yilmaz Cakaloglu
@nl